Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

Similar articles for PubMed (Select 24758072)

1.

[The significance of introducing registry study in the post-marketing safety research for Chinese medicine and pharmacy].

Liao X, Xie YM, Yang W, Chang YP.

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2014 Mar;34(3):261-6. Chinese.

PMID:
24758072
2.

[Sample size calculation in clinical post-marketing evaluation of traditional Chinese medicine].

Fu Y, Xie Y.

Zhongguo Zhong Yao Za Zhi. 2011 Oct;36(20):2904-6. Chinese.

PMID:
22292397
3.

[Explore method about post-marketing safety re-evaluation of Chinese patent medicines based on HIS database in real world].

Yang W, Xie Y, Zhuang Y.

Zhongguo Zhong Yao Za Zhi. 2011 Oct;36(20):2779-82. Chinese.

PMID:
22292363
4.

[Study on method on post-marketing traditonal Chinese medicine safety assessment].

Kou Q, Zhao S, Feng G, Xie Y.

Zhongguo Zhong Yao Za Zhi. 2011 Oct;36(20):2771-5. Chinese.

PMID:
22292361
5.

[Necessity of applying pharmacovigilance in post-marketing safety monitoring of traditional Chinese medicine injections].

Wang HN, Chen W, Fu Z, Du WM, He J.

Zhongguo Zhong Yao Za Zhi. 2008 Mar;33(5):612-4. Chinese.

PMID:
18536393
6.

[Application of Markov model in post-marketing pharmacoeconomic evaluation of traditional Chinese medicine].

Wang X, Su X, Sun W, Xie Y, Wang Y.

Zhongguo Zhong Yao Za Zhi. 2011 Oct;36(20):2844-7. Chinese.

PMID:
22292381
7.

[Research about re-evaluation of screening of traditonal Chinese medicine symptoms item of post-marketing medicine Xuezhikang].

He W, Xie Y, Wang Y.

Zhongguo Zhong Yao Za Zhi. 2011 Oct;36(20):2898-900. Chinese.

PMID:
22292395
8.

What can comparative effectiveness research, propensity score and registry study bring to Chinese medicine?

Liao X, Xie YM.

Chin J Integr Med. 2014 Oct;20(10):792-5. doi: 10.1007/s11655-013-1662-9. Epub 2014 Mar 7.

PMID:
24615256
9.

[Thinking on risk assessment and risk management of post-marketing Chinese medicine].

Yu X, Xie Y, Wang Y.

Zhongguo Zhong Yao Za Zhi. 2012 Jan;37(2):262-4. Chinese.

PMID:
22737865
10.

Methodological approaches to developing and establishing the body of evidence on post-marketing Chinese medicine safety.

Liao X, Robinson N.

Chin J Integr Med. 2013 Jul;19(7):494-7. doi: 10.1007/s11655-013-1502-y. Epub 2013 Jul 2.

PMID:
23818200
11.

[Basic requirements on post-marketing clinical re-evaluation of chinese medicine and phase IV clinical trials].

Xie Y, Wang Y, Tian F, Wang Y.

Zhongguo Zhong Yao Za Zhi. 2011 Oct;36(20):2764-7. Chinese.

PMID:
22292359
12.

[Application of nested case-control study on safe evaluation of post-marketing traditional Chinese medicine injection].

Xiao Y, Zhao Y, Xie Y.

Zhongguo Zhong Yao Za Zhi. 2011 Oct;36(20):2796-8. Chinese.

PMID:
22292368
13.

[Case study of Chinese medicine after listing of pharmacovigilance].

Xiang Y, Xie Y, Yi D.

Zhongguo Zhong Yao Za Zhi. 2011 Oct;36(20):2836-9. Chinese.

PMID:
22292379
14.

[Discussion on implications and research ideas of toxic theory in natural characteristics of Chinese herbal medicine].

Wu J, Zhang B, Chang Z.

Zhongguo Zhong Yao Za Zhi. 2009 Feb;34(4):480-2. Chinese.

PMID:
19459317
15.

[Clinical orientation and thought on several problems in post-marketed reassessment of traditional Chinese medicine].

Wang X, Su X, Yu J, Xie Y, Wang Y.

Zhongguo Zhong Yao Za Zhi. 2011 Oct;36(20):2893-7. Chinese.

PMID:
22292394
16.
17.

[Time to see the risks associated with traditional Chinese medicine].

Viidik A.

Lakartidningen. 2012 May 14-29;109(20-21):1004-5. Swedish. No abstract available.

PMID:
22741403
18.

[Construction and realization of real world integrated data warehouse from HIS on re-evaluation of post-maketing traditional Chinese medicine].

Zhuang Y, Xie B, Weng S, Xie Y.

Zhongguo Zhong Yao Za Zhi. 2011 Oct;36(20):2883-7. Chinese.

PMID:
22292392
19.

[Post-marketing re-evaluation about usage and dosage of Chinese medicine based on human population pharmacokinetics].

Jiang J, Xie Y.

Zhongguo Zhong Yao Za Zhi. 2011 Oct;36(20):2811-2. Chinese.

PMID:
22292372
20.

[Safety evaluation of Chinese medicine on tumor therapy].

Liu R, Hua BJ, Li J.

Zhongguo Zhong Yao Za Zhi. 2013 Dec;38(23):4181-4. Review. Chinese.

PMID:
24791513
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk